Inauguration Ceremony Marks Landmark Occasion for Regenerative Medicine in the
Region

April 22, 2024 – Global Stem Cells Group (GSCG) and ReGen proudly
announce the formal integration of Churchill Aesthetic Center into ReGen’s
distinguished membership in Brussels, Belgium. The opening ceremony, graced by
esteemed leaders in the field of regenerative medicine, signifies a momentous stride
forward for healthcare in the region. Distinguished attendees included Dr. Salih Yildirim,
Director of ReGen and President of the International Society for Stem Cell Application
(ISSCA), Benito Novas, Director of Public Relations for ISSCA and founder of the Global
Stem Cells Group, and Dr. Samy Joheir, President of the Churchill Aesthetic Center.

The opening ceremony not only commemorated the Churchill Aesthetic Center’s
membership celebration, but also featured an advanced hair transplant course for local
and international physicians, presenting the latest advances in aesthetic and
regenerative medicine, including cutting-edge Turkish techniques in hair transplantation
along with stem cell applications, with the goal of raising the standards of care and
treatment outcomes in the region.

Expressing his profound satisfaction, Dr. Salih Yildirim remarked, “Expanding our
footprint to Brussels, Belgium, and upcoming clinics in Albania and Antalya, fills me with
immense pride and purpose. It is a privilege to extend the transformative benefits of
regenerative medicine to the people of Belgium.”

Benito Novas further emphasized, “Our mission extends beyond borders; it is to propel
the global movement of Regenerative Medicine, enriching lives and advancing
healthcare standards worldwide. Regenerative medicine is not merely a promise for the
future; it is the cornerstone of contemporary healthcare.”

The newly established center is poised to serve as a pivotal training hub for ISSCA,
facilitating the dissemination of knowledge and expertise among healthcare
professionals in the region, thereby fostering continuous advancements in the field of
regenerative medicine.

The strategic partnership between Global Stem Cells Group and ReGen has led to
remarkable growth, establishing pioneering clinics worldwide. This partnership reflects

GSCG’s commitment to global accessibility, with ReGen providing clinics and expertise,
while GSCG contributes invaluable resources and comprehensive training through
ISSCA. Together, they aim to positively impact countless lives worldwide.

About Global Stem Cells Group
Global Stem Cells Group is a leading provider of regenerative medicine solutions,
dedicated to advancing healthcare through innovative therapies. With a global presence
and a multidisciplinary team of experts, the organization strives to harness the potential
of stem cells and regenerative medicine to improve patient outcomes across various
medical fields. Through its extensive network of clinics, research facilities, and training
centers, Global Stem Cells Group is committed to pushing the boundaries of
regenerative medicine and making a positive impact on global healthcare.

About ReGen
ReGen is a highly acclaimed Turkish company with clinics in Turkey and in several other
locations around the world, renowned for its expertise in cutting-edge technologies
related to regenerative care. Headquartered in Istanbul, ReGen has gained international
recognition for its commitment to excellence and its groundbreaking advancements in
regenerative medicine. By partnering with Global Stem Cells Group, ReGen aims to
share its advanced techniques and expertise on a global scale, improving access to
regenerative care and transforming lives worldwide.

Miami, Florida – The International Society for Stem Cell Application (ISSCA), a
distinguished division of the Global Stem Cells Group (GSCG), is excited to announce its
highly anticipated international conference on Regenerative Medicine and Cellular
Therapies. Scheduled to unfold in the dynamic city of Lima, Peru, this groundbreaking
event will span two immersive days, from September 6th to 7th, 2024. Day one will be
dedicated to enlightening conferences, while day two will offer hands-on sessions,
providing attendees with a comprehensive learning experience.

Renowned urologist Dr. Jorge Saldaña, certified by ISSCA and highly regarded in the
region, will play a key role in organizing the conference. The event will also serve as the
venue for Dr. Saldaña’s appointment as the director of the ISSCA chapter in Peru. This
significant appointment is scheduled for September 6th, further underscoring his
dedication to advancing regenerative medicine not only in Peru but also in neighboring
regions of Latin America.

The conference aims to assemble leading scientists and medical professionals
worldwide, offering a unique platform to explore and discuss the latest advancements
in regenerative medicine. With an array of elite speakers, including distinguished
scientists and physicians renowned for their contributions to the field, attendees can
anticipate gaining profound insights into the cutting-edge clinical applications of stem
cell therapies.

Attendees are expected to be at the forefront of revolutionary technologies in
regenerative medicine. From the latest breakthroughs reshaping healthcare to
innovative tools enhancing clinical practice, participants will uncover advancements
poised to elevate their practice and enhance patient care.

This conference provides a holistic understanding of regenerative medicine, spanning
foundational principles to cutting-edge applications. Attendees are anticipated to leave
equipped with the essential knowledge to navigate the rapidly evolving landscape of
regenerative medicine.

Beyond theoretical discourse, the conference offers invaluable hands-on training
sessions led by ISSCA-certified instructors. Attendees will gain practical experience in
both aesthetic and clinical applications of stem cell therapy, ensuring they leave
equipped with skills ready for immediate implementation.

ISSCA is proud to bring its expertise back to Lima, Peru, reaffirming its presence in the
southern cone with this global conference. Benito Novas, founder of Global Stem Cells
Group and head of relationships of ISSCA, expresses his excitement, stating, “I’m thrilled
to return to Peru with new technologies in the field of regenerative medicine. We will be
providing local doctors and neighboring regions with the latest advancements in the
field. Regenerative medicine is the future of healthcare as more research is conducted
and products are developed to offer superior services.”

Benito adds,”The conference will feature world-renowned experts engaging directly with
live trainees and patients to impart diverse cellular and procedural therapy techniques.
These sessions will utilize locally available tools, ensuring practical applicability and
relevance to the attendees’ contexts.”

As an acclaimed stakeholder in regenerative medicine and stem cell therapy, ISSCA
offers a globally recognized certification to physicians and professionals, highlighting
its fascinating track record in this highly sought-after field. According to Dr. Saldaña,
“ISSCA has always been a pioneer in the world of regenerative medicine, serving as a
worldwide reference. Having them here once again with their world conference is a
fantastic opportunity, and I’m genuinely delighted to be part of this momentous event”

The Conference considers the needs of local trainees using a thorough scheduling
process. Initial consultations between the trainees and ISSCA will inform equipment and
kits availability, materials, underlying costs, and any other needs to be met during the
main event.

About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary
community of scientists and physicians who aspire to treat diseases and lessen human
suffering through advances in science, technology, and the practice of regenerative
medicine. ISSCA serves its members through advancements made in the specialty of
regenerative medicine.

The mission of ISSCA is to establish itself as a global leader in regenerative medicine
certification, education, research, and training.

ISSCA provides certification training in cities worldwide because it recognizes the
importance of standards and certifications in regenerative medicine as a medical
specialty. To help more people, both locally and globally, as the demand for more
doctors interested in and comfortable with regenerative medicine surges. ISSCA’s
mission is to advance quality and uniformity in regenerative medicine worldwide.

About Global Stem Cells Group:
The Global Stem Cell Group is a family of several companies focused on stem cell
medicine and research. The company uses its network to bring leadership in
regenerative medicine training, research, and patient applications.
GSCG’s mission is to allow physicians to present the benefits of stem cell medicine to
patients worldwide. The company also partners with policymakers, educators, and
regulators to promote regenerative medicine.
Global Stem Cells Group is a publicly traded company operating under the symbol
MSSV. https://finance.yahoo.com/quote/mssv/
To learn more about Global Stem Cells Group, Inc.’s companies visit our website
www.stemcellsgroup.com or call +1 305 560 5331

Safe Harbor Statement:
Statements in this news release may be “forward-looking statements”. Forward-looking
statements include, but are not limited to, statements that express our intentions,
beliefs, expectations, strategies, predictions, or any other information relating to our
future activities or other future events or conditions. These statements are based on
current expectations, estimates, and projections about our business based partly on
assumptions made by management. These statements are not guarantees of future
performance and involve risks, uncertainties, and assumptions that are difficult to
predict. Therefore, actual outcomes and results may and are likely to differ materially
from what is expressed or forecasted in forward-looking statements due to numerous
factors. Any forward-looking statements speak only as of the date of this news release,
and The Global Stem Cells Group undertakes no obligation to update any forward-
looking statement to reflect events or circumstances after the date of this news release.
This press release does not constitute a public offer of any securities for sale. Any
securities offered privately will not be or have not been registered under the Act and
may not be offered or sold in the United States absent registration or an applicable
exemption from registration requirements.

ISSCA Presents Regenerative Medicine World Congress and Promotes CGELL Technology Training

MIAMI, FL, April 2022 – The International Society for Stem Cell Application has announced plans to become a sponsor at this year’s IMCAS 2022 World Congress. From June 3rd to June 5th, 2022, dermatologists, plastic surgeons, and aesthetic practitioners will gather in Paris for the world’s largest aging science and aesthetic learning event. The International Society for Stem Cell Application (ISSCA) will be present, providing invaluable information about its innovative GCELL technology. Regenerative Medicine Certification program for physicians training and Promoting its Regenerative Medicine World Congress to be held in Istanbul turkey late September 

Cellular therapy is becoming standard practice in regenerative aesthetics due to its effectiveness and safety compared to existing treatment options Advanced technologies such as GCELL constitute a valuable therapeutic tool. Physicians specializing in dermatology, wound care, cosmetic gynecology, aesthetic medicine, hair transplants, and alopecia. Event participants will have a unique opportunity to learn about GCELL technology and ISSCA training programs 

. Interested IMCAS  attendees can visit the ISSCA and learn more about GCELL technology and ISSCA’s Regenerative Medicine World Congress at Booth 999  your spot, visit https://www.issca.us/world-congress/. 

ISSCA is back for the second year in a row after a brief hiatus due to Covid with its annual ISSCA World Congress Of Regenerative Medicine 2022 for the Advancement of Cellular Therapies and Technology in Istanbul, Turkey.

[Istanbul, Turkey, 19/Jan/2022] —  The International Society for Stem Cell Applications, ISSCA, is again having the most anticipated regenerative medicine occasion of the year September 22-24, 2022. The non-profit association is celebrated worldwide for conveying the benefits of regenerative medicine to nations worldwide and nurturing an international congregation of world-class scientists and doctors from more than 35 countries via its conferences—the last of which took place on May 27-28th at the Pullman Istanbul Hotel & Convention Center.

The congress concentrates on getting physicians together from all over the world with three full days of conferences and workshops, such as the aesthetic applications workshop and the clinical applications workshop. Throughout this event, physicians and researchers speak with panels to discuss the recent advancements in the quickly expanding field of regenerative medicine; top among these are:

●       Molecular biology.

●       New models of treatment in surgical and cosmetic applications.

●       The latest technological advancements hit the area.

This conference includes a panel on Cellgenic Exosomes, which stems from years of progress towards discovering a regenerative medicine development to reduce harsh operating room time. The accumulation of this data serves one purpose– more effective treatment of degenerative disease worldwide with up-to-date therapeutic applications of stem cells.

Additionally, the conference also discusses the legal terrain for the practice of regenerative medicine as it offers itself around the world, meaning multiple national governments have input to some degree. Lectures are held over the course of the day at this congress, which is part of ISSCA’s mission to sustain a paradigm shift from conventional healthcare answers to regenerative medicine and deliver the latest ingenious findings and expansions in all areas of stem cell research.

The conference is held at the elegant Hotel Hyatt Regency, located near Istanbul’s Ataturk Airport. The hotel offers guests the medley of convenience, culture, and comfort while touring the ancient city, Turkey’s epicenter of entertainment and rich history. Congress attendees will uncover sceneries such as the Hagia Sophia and the Blue Mosque.

ISSCA Vice President Benito Novas had this to say about the conference: “It feels amazing to be back out– after so long with lockdowns and traveling difficulties, we were wondering if we would have to wait even longer to host an event. But, of course, it’s been far from ideal– even if the world locks down, research continues, and breakthroughs come through in our field of regenerative medicine month after month. Our ISSCA Congresses provide a great opportunity to spread this information out to the physicians who need it the most, and we plan to host as many as we can before the end of the year.”

Join the group of doctors looking for new alternatives for their patients by registering today to partake in ISSCA’s forthcoming events! Get ready to scale up your knowledge!

For more info, visit our website at https://www.issca.us/, email info@stemcellsgroup.com, or call +1305 560 5337.

 
About International Society for Stem Cells Applications

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary society of physicians and scientists aspiring to treat diseases through advances in science, tech, and regenerative medicine. ISSCA helps its members through advancements made to the specialty of regenerative medicine.

Regenerative medicine standards and certifications are critical, which is why ISSCA delivers certificate training worldwide. The objective is to inspire more doctors to practice regenerative medicine and open it globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.